Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Lilly and Parexel Partner on Asia-Pacific Clinical Trials

publication date: Sep 21, 2010
Eli Lilly has partnered with Parexel, a global CRO based in the US, to support its clinical trials in the Asia-Pacific region. Parexel will be given the job of assisting Lilly in Asia and Australia with clinical trial start-up and site monitoring. Lilly has followed a partnership approach on its R&D work in China, and now it has implemented a similar model for conducting clinical trials. More details....

Stock Symbols: (NYSE LLY)  (NSDQ: PRXL)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital